Skip to main content
Caplight Logo









CureMetrix

CureMetrix

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://curemetrix.com/

Last Round

Series C

Sep 17, 2024

Total Funding Raised

$30M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

CureMetrix is a healthcare technology company that develops artificial intelligence-based software for medical image analysis, primarily focused on mammography and breast health.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Healthcare Analytics, Computer Vision

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

medical imaging AImammography AIcomputer-aided detectionCADbreast cancer detectionradiology workflowbreast arterial calcificationBACbreast density classificationradiology AIclinical decision supportFDA-cleared AImedical softwareAI triageradiology tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CureMetrix Comparables

Compare CureMetrix with similar companies based on industry and business-model similarity.

CureMetrix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Whiterabbit.ai
87%
Densitas Inc.
86%
Therapixel
84%

CureMetrix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CSep 17, 2024
SeedMay 13, 2015
AcceleratorAug 1, 2014

Key People

Founding team and executive leadership

Navid Alipour

Chief Executive Officer, Co-Founder Board Member

Founding Team

Tom Saftig

CFO

Executive Team

CureMetrix Investors

Notable investors and investment history

CureMetrix investors
InvestorRounds
Analytics VenturesSeed, Accelerator
EvoNexusAccelerator, Seed
XB VenturesSeries C
Keshif VenturesSeed, Accelerator
UnitleaderSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 45% MoM.

  • Jan 21, 2026

    Monthly visitors increased 60% MoM.

CureMetrix Filings

Explore SEC and related filing metadata, where available.

CureMetrix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CureMetrix's valuation, stock price, and market status.

Is CureMetrix a public or private company?

CureMetrix is a private company.

What is the current stock price of CureMetrix?

CureMetrix is a private company with no public stock price. No recent secondary market data is available.

How much is CureMetrix worth (valuation)?

Valuation information for CureMetrix is not publicly available.

Can I buy CureMetrix stock?

CureMetrix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CureMetrix's last funding round?

Funding round information for CureMetrix is not publicly available.

Who are the main investors in CureMetrix?

Investor information for CureMetrix is not publicly disclosed.

Will CureMetrix IPO soon?

No public IPO plans have been announced for CureMetrix.

How can I track CureMetrix secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CureMetrix's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Employee Range38
Year Founded2014
Last FundingSep 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?